Real-time enrollment status for this chronic myelomonocytic leukemia clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:28 PM UTC
| NCT Number | NCT04239157 |
| Recruiting Status | Recruiting |
| Condition | Chronic Myelomonocytic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 76 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of August 30, 2026: Clinical trial NCT04239157 is currently recruiting participants. This phase2 study for chronic myelomonocytic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04239157 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04239157 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.